NORTHBROOK, Ill., Oct. 30,
2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) today
reported:
Third Quarter 2024 Highlights
- Reported net income was $23.6
million, up 88% versus prior year. Adjusted net
income(1) was $23.7
million, up 61% versus prior year, largely due to higher
margins and a lower effective tax rate. The year-over-year change
in effective tax rate positively impacted net income by
$6.8 million, or $0.30 per diluted share.
- EBITDA(2) was $53.0
million and Adjusted EBITDA(2) was $53.1 million, up 18% and 11% respectively,
year-over-year.
- Global sales volume was down 1% year-over-year. Double digit
growth in several Surfactant end markets was fully offset by demand
weakness in Polymers.
- Cash from Operations was $22.7
million during the quarter. Free cash flow(3) for
the quarter was a negative $4.0
million.
- The Company is on track to deliver its $50 million cost out goal for 2024 and recognized
$13.3 million in pre-tax savings in
the third quarter.
YTD 2024 Highlights
- Reported net income was $47.0
million, up 14% versus prior year. Adjusted net
income(1) was $47.7
million, up 10% year-over-year.
- EBITDA(2) was $151.0
million and Adjusted EBITDA(2) was $151.9 million, up 8% and 7% respectively,
year-over-year.
- Global sales volume was up 1% year-over-year.
"Team Stepan delivered a solid quarter despite significant
challenges. Third quarter adjusted EBITDA grew double digits driven
by the Surfactant and Specialty Product businesses. Surfactants
continued its volume recovery and experienced double-digit volume
growth within the Agricultural, Oilfield and the Construction
and Industrial Solutions end markets and also with our Distribution
partners. Latin America Surfactant volume grew mid-single digits
driven by strong demand within the Agricultural end markets in
Brazil and new contracted business
in Mexico," said Luis E.
Rojo, President and Chief Executive Officer. "Rigid Polyol
volume was down 13% during the quarter due to soft demand and
competitive pressures. We believe the sluggish demand is related to
global macro-economic uncertainties including the high interest
rate environment. Specialty Polyols volume and margins were up
during the quarter. Global margins continue to improve and remain
in line with expectations. Free Cash Flow for the quarter was in
line with our expectations as we built inventory levels for the
hurricane season and in anticipation of two Polymer plant
turnarounds in October. The third quarter results are a testament
to the resilience of Team Stepan and give us a strong base to
grow from."
Financial Summary
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in thousands,
except per share data)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Net Sales
|
|
$
|
546,842
|
|
|
$
|
562,226
|
|
|
|
(3)
|
%
|
|
$
|
1,654,665
|
|
|
$
|
1,793,637
|
|
|
|
(8)
|
%
|
Operating
Income
|
|
$
|
23,949
|
|
|
$
|
19,517
|
|
|
|
23
|
%
|
|
$
|
62,785
|
|
|
$
|
58,383
|
|
|
|
8
|
%
|
Net Income
|
|
$
|
23,606
|
|
|
$
|
12,571
|
|
|
|
88
|
%
|
|
$
|
47,020
|
|
|
$
|
41,397
|
|
|
|
14
|
%
|
Earnings per Diluted
Share
|
|
$
|
1.03
|
|
|
$
|
0.55
|
|
|
|
87
|
%
|
|
$
|
2.05
|
|
|
$
|
1.80
|
|
|
|
14
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Net Income
*
|
|
$
|
23,661
|
|
|
$
|
14,730
|
|
|
|
61
|
%
|
|
$
|
47,713
|
|
|
$
|
43,206
|
|
|
|
10
|
%
|
Adjusted Earnings
per
Diluted Share *
|
|
$
|
1.03
|
|
|
$
|
0.64
|
|
|
|
61
|
%
|
|
$
|
2.08
|
|
|
$
|
1.88
|
|
|
|
11
|
%
|
|
|
* See Table II for
reconciliations of non-GAAP adjusted net income and adjusted
earnings per diluted share.
|
|
Percentage Change in Net Sales
Net sales in the third quarter of 2024 decreased 3%
year-over-year. The decline in net sales was impacted equally by a
1% drop in volume, lower selling prices and foreign currency
translation.
|
|
Three Months
Ended
September 30, 2024
|
|
|
Nine Months
Ended
September 30, 2024
|
|
Volume
|
|
|
(1)
|
%
|
|
|
1
|
%
|
Selling Price &
Mix
|
|
|
(1)
|
%
|
|
|
(9)
|
%
|
Foreign
Translation
|
|
|
(1)
|
%
|
|
|
(—)
|
%
|
Total
|
|
|
(3)
|
%
|
|
|
(8)
|
%
|
Segment Results
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in
thousands)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Net
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
382,724
|
|
|
$
|
373,836
|
|
|
|
2
|
%
|
|
$
|
1,153,339
|
|
|
$
|
1,233,351
|
|
|
|
(6)
|
%
|
Polymers
|
|
$
|
149,796
|
|
|
$
|
169,559
|
|
|
|
(12)
|
%
|
|
$
|
455,061
|
|
|
$
|
495,200
|
|
|
|
(8)
|
%
|
Specialty
Products
|
|
$
|
14,322
|
|
|
$
|
18,831
|
|
|
|
(24)
|
%
|
|
$
|
46,265
|
|
|
$
|
65,086
|
|
|
|
(29)
|
%
|
Total Net
Sales
|
|
$
|
546,842
|
|
|
$
|
562,226
|
|
|
|
(3)
|
%
|
|
$
|
1,654,665
|
|
|
$
|
1,793,637
|
|
|
|
(8)
|
%
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in thousands, all
amounts pre-tax)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Operating
Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
26,303
|
|
|
$
|
15,373
|
|
|
|
71
|
%
|
|
$
|
69,445
|
|
|
$
|
57,570
|
|
|
|
21
|
%
|
Polymers
|
|
$
|
15,248
|
|
|
$
|
21,813
|
|
|
|
(30)
|
%
|
|
$
|
37,227
|
|
|
$
|
48,137
|
|
|
|
(23)
|
%
|
Specialty
Products
|
|
$
|
3,727
|
|
|
$
|
2,402
|
|
|
|
55
|
%
|
|
$
|
15,314
|
|
|
$
|
8,704
|
|
|
|
76
|
%
|
Total Segment
Operating Income
|
|
$
|
45,278
|
|
|
$
|
39,588
|
|
|
|
14
|
%
|
|
$
|
121,986
|
|
|
$
|
114,411
|
|
|
|
7
|
%
|
Corporate
Expenses
|
|
$
|
(21,329)
|
|
|
$
|
(20,071)
|
|
|
|
6
|
%
|
|
$
|
(59,201)
|
|
|
$
|
(56,028)
|
|
|
|
6
|
%
|
Consolidated
Operating Income
|
|
$
|
23,949
|
|
|
$
|
19,517
|
|
|
|
23
|
%
|
|
$
|
62,785
|
|
|
$
|
58,383
|
|
|
|
8
|
%
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in
millions)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
EBITDA
|
|
$
|
53.0
|
|
|
$
|
45.1
|
|
|
|
18
|
%
|
|
$
|
151.0
|
|
|
$
|
140.1
|
|
|
|
8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
44.2
|
|
|
$
|
31.6
|
|
|
|
40
|
%
|
|
$
|
122.9
|
|
|
$
|
105.1
|
|
|
|
17
|
%
|
Polymers
|
|
$
|
23.4
|
|
|
$
|
29.7
|
|
|
|
(21)
|
%
|
|
$
|
61.6
|
|
|
$
|
72.6
|
|
|
|
(15)
|
%
|
Specialty
Products
|
|
$
|
5.2
|
|
|
$
|
3.9
|
|
|
|
33
|
%
|
|
$
|
19.8
|
|
|
$
|
13.0
|
|
|
|
52
|
%
|
Unallocated Corporate
|
|
$
|
(19.7)
|
|
|
$
|
(17.2)
|
|
|
|
15
|
%
|
|
$
|
(52.4)
|
|
|
$
|
(48.2)
|
|
|
|
9
|
%
|
Consolidated
Adjusted EBITDA
|
|
$
|
53.1
|
|
|
$
|
48.0
|
|
|
|
11
|
%
|
|
$
|
151.9
|
|
|
$
|
142.5
|
|
|
|
7
|
%
|
Consolidated operating income increased $4.4 million, or 23%, year-over-year.
Consolidated adjusted EBITDA increased $5.1
million, or 11%, year-over-year driven by higher Surfactant
volume and margins, partially offset by demand weakness in
Polymers.
- Surfactant net sales were $382.7
million for the quarter, a 2% increase versus the prior
year. Selling prices were up 1% primarily due to improved product
and customer mix. Sales volume was up 3% year-over-year primarily
due to double digit growth within the Agricultural, Oilfield and
the Construction and Industrial Solutions end markets along with
our distribution partners. This growth was partially offset by
lower demand within the Consumer Products end markets. Foreign
currency translation negatively impacted net sales by 2%.
Surfactant operating income for the quarter increased $10.9 million, or 71%, versus the prior year.
Surfactant adjusted EBITDA(2) increased $12.6 million, or 40%, versus the prior year.
This increase was primarily driven by the 3% growth in sales volume
and margin improvement that was partially offset by pre-operating
expenses at the Company's new alkoxylation facility being built in
Pasadena, Texas.
- Polymer net sales were $149.8
million for the quarter, a 12% decrease versus the prior
year. Selling prices decreased 3%, primarily due to the
pass-through of lower raw material costs and competitive pressures.
Sales volume declined 11% in the quarter primarily due to a 13%
decrease in global Rigid Polyols demand and a 27% decrease in
commodity Phthalic Anhydride volume. Specialty Polyols volume was
up year-over-year. Foreign currency translation positively impacted
net sales by 2%. Polymer operating income decreased $6.6 million, or 30%, versus the prior year.
Polymer adjusted EBITDA(2) decreased $6.3 million, or 21%, versus the prior year
primarily due to the 11% decline in sales volume.
- Specialty Product net sales were $14.3
million for the quarter, a 24% decrease versus the prior
year, primarily due to lower selling prices. Sales volume was down
5% versus the prior year. Specialty Product operating income
increased $1.3 million, or 55%,
versus the prior year. Specialty Product adjusted
EBITDA(2) increased $1.3
million, or 33%. The increase in adjusted
EBITDA(2) was primarily due to higher unit margins
within the medium chain triglycerides product line.
Income Taxes
The Company's effective tax rate was a negative 10.7% during the
third quarter of 2024 versus 20.6% in the third quarter of
2023. The decrease was primarily attributable to the
Company's intention to make an election under the U.S. GILTI tax
regime to exclude certain high taxed entities from the GILTI
computation. The Company's effective tax rate was 18.9% for the
first nine months of 2024 versus 20.5% for the first nine months of
2023.
Outlook
"Team Stepan continues to be focused on executing our
strategic growth projects. We are pleased that several of our
Surfactant businesses continue to deliver strong volume growth.
Agricultural volumes grew double-digits in the third quarter which
aligns with our expectations for a second half 2024 recovery. We
remain optimistic Rigid Polyol demand will increase as
the market gets more macro-economic clarity and the interest rate
environment improves," said Luis E.
Rojo, President and Chief Executive Officer. "Free cash flow
should continue to improve versus prior year driven by the
completion of our Pasadena
investment, growth in market volumes, and our continued focus on
cost reduction. We believe we are positioned to deliver full year
Adjusted EBITDA growth and positive free cash flow."
Notes
|
(1) Adjusted net
income and adjusted earnings per share are non-GAAP measures which
exclude deferred compensation income/expense, cash-settled stock
appreciation rights (SARs) income/expense, certain environmental
remediation-related costs as well as other significant and
infrequent/non-recurring items. See Table II for reconciliations of
non-GAAP adjusted net income and adjusted earnings per diluted
share.
|
|
(2) EBITDA and
adjusted EBITDA are non-GAAP measures. See Table VI for
calculations and GAAP reconciliations of EBITDA and adjusted
EBITDA.
|
|
(3) Free cash flow
is a non-GAAP measure and reflects cash generated from operations
minus capital expenditures. Cash generated from operations was
$22.7 million during the third quarter of 2024 and capital
expenditures were $26.7 million.
|
Conference Call
Stepan Company will host a conference call to discuss its second
quarter results at 9:00 a.m. ET
(8:00 a.m. CT) on October 30, 2024. The call can be accessed by
phone and webcast. To access the call by phone, please click on
this Registration Link, complete the form and you will be provided
with dial in details and a PIN. To avoid delays, we encourage
participants to dial into the conference call ten minutes ahead of
the scheduled start time. The webcast can be accessed through
the Investors/Conference Calls page at www.stepan.com.
A webcast replay of the conference call will be available at the
same location shortly after the call.
Supporting Slides
Slides supporting this press release will be made available at
www.stepan.com through the Investors/Presentations page at
approximately the same time as this press release is issued.
Corporate Profile
Stepan Company is a major manufacturer of specialty and
intermediate chemicals used in a broad range of industries. Stepan
is a leading merchant producer of surfactants, which are the key
ingredients in consumer and industrial cleaning and disinfection
compounds and in agricultural and oilfield solutions. The Company
is also a leading supplier of polyurethane polyols used in the
expanding thermal insulation market, and CASE (Coatings, Adhesives,
Sealants, and Elastomers) industries.
Headquartered in Northbrook,
Illinois, Stepan utilizes a network of modern production
facilities located in North and South
America, Europe and
Asia.
The Company's common stock is traded on the New York Stock
Exchange (NYSE) under the symbol SCL. For more information about
Stepan Company please visit the Company online at
www.stepan.com
More information about Stepan's sustainability program can be
found on the Sustainability page at www.stepan.com
Certain information in this news release consists of
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements
include statements about Stepan Company's plans, objectives,
strategies, financial performance and outlook, trends, the amount
and timing of future cash distributions, prospects or future events
and involve known and unknown risks that are difficult to predict.
As a result, Stepan Company's actual financial results,
performance, achievements or prospects may differ materially from
those expressed or implied by these forward-looking statements. In
some cases, you can identify forward-looking statements by the use
of words such as "may," "could," "expect," "intend," "plan,"
"seek," "anticipate," "believe," "estimate," "guidance," "predict,"
"potential," "continue," "likely," "will," "would," "should,"
"illustrative" and variations of these terms and similar
expressions, or the negative of these terms or similar expressions.
Such forward-looking statements are necessarily based upon
estimates and assumptions that, while considered reasonable by
Stepan Company and its management based on their knowledge and
understanding of the business and industry, are inherently
uncertain. These statements are not guarantees of future
performance, and stockholders should not place undue reliance on
forward-looking statements.
There are a number of risks, uncertainties and other
important factors, many of which are beyond Stepan Company's
control, that could cause actual results to differ materially from
the forward-looking statements contained in this news release. Such
risks, uncertainties and other important factors include, among
other factors, the risks, uncertainties and factors described in
Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and
exhibits to those reports, and include (but are not limited to)
risks and uncertainties related to accidents, unplanned
production shutdowns or disruptions in manufacturing facilities;
reduced demand due to customer product reformulations or new
technologies; our inability to successfully develop or introduce
new products; compliance with laws; our ability to identify
suitable acquisition candidates and successfully complete and
integrate acquisitions; global competition; volatility of raw
material and energy costs and supply; disruptions in transportation
or significant changes in transportation costs; downturns in
certain industries and general economic downturns; international
business risks, including currency exchange rate fluctuations,
legal restrictions and taxes; unfavorable resolution of litigation
against us; maintaining and protecting intellectual property
rights; our ability to access capital markets; global political,
military, security or other instability; costs related to expansion
or other capital projects; interruption or breaches of information
technology systems; our ability to retain executive management and
key personnel; and our debt covenants.
These forward-looking statements are made only as of the date
hereof, and Stepan Company undertakes no obligation to update or
revise these forward-looking statements, whether as a result of new
information, future events or otherwise.
Tables follow
Table
I
|
|
|
|
STEPAN
COMPANY For the Three and Nine Months Ended September 30,
2024 and 2023 (Unaudited – in 000's, except per share
data)
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Net
Sales
|
|
$
|
546,842
|
|
|
$
|
562,226
|
|
|
$
|
1,654,665
|
|
|
$
|
1,793,637
|
|
Cost of
Sales
|
|
|
471,157
|
|
|
|
490,990
|
|
|
|
1,439,147
|
|
|
|
1,582,444
|
|
Gross
Profit
|
|
|
75,685
|
|
|
|
71,236
|
|
|
|
215,518
|
|
|
|
211,193
|
|
Operating
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
11,394
|
|
|
|
11,811
|
|
|
|
34,610
|
|
|
|
35,987
|
|
Administrative
|
|
|
26,254
|
|
|
|
22,904
|
|
|
|
73,513
|
|
|
|
68,132
|
|
Research, Development
and Technical Services
|
|
|
13,532
|
|
|
|
14,477
|
|
|
|
41,881
|
|
|
|
43,720
|
|
Deferred Compensation
Expense
|
|
|
556
|
|
|
|
(3,101)
|
|
|
|
2,729
|
|
|
|
(856)
|
|
|
|
|
51,736
|
|
|
|
46,091
|
|
|
|
152,733
|
|
|
|
146,983
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business Restructuring
Expense
|
|
|
-
|
|
|
|
5,628
|
|
|
|
-
|
|
|
|
5,827
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income
|
|
|
23,949
|
|
|
|
19,517
|
|
|
|
62,785
|
|
|
|
58,383
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income
(Expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest,
Net
|
|
|
(3,621)
|
|
|
|
(2,987)
|
|
|
|
(9,353)
|
|
|
|
(9,674)
|
|
Other, Net
|
|
|
989
|
|
|
|
(690)
|
|
|
|
4,551
|
|
|
|
3,348
|
|
|
|
|
(2,632)
|
|
|
|
(3,677)
|
|
|
|
(4,802)
|
|
|
|
(6,326)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Before
Provision for Income Taxes
|
|
|
21,317
|
|
|
|
15,840
|
|
|
|
57,983
|
|
|
|
52,057
|
|
Provision for Income
Taxes
|
|
|
(2,289)
|
|
|
|
3,269
|
|
|
|
10,963
|
|
|
|
10,660
|
|
Net
Income
|
|
|
23,606
|
|
|
|
12,571
|
|
|
|
47,020
|
|
|
|
41,397
|
|
Net Income Per
Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.03
|
|
|
$
|
0.55
|
|
|
$
|
2.06
|
|
|
$
|
1.82
|
|
Diluted
|
|
$
|
1.03
|
|
|
$
|
0.55
|
|
|
$
|
2.05
|
|
|
$
|
1.80
|
|
Shares Used to
Compute Net Income Per
Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
22,836
|
|
|
|
22,786
|
|
|
|
22,829
|
|
|
|
22,770
|
|
Diluted
|
|
|
22,923
|
|
|
|
22,930
|
|
|
|
22,936
|
|
|
|
22,956
|
|
Table
II
|
|
|
|
Reconciliation of
Non-GAAP Net Income and Earnings per Diluted Share*
|
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in thousands,
except per share amounts)
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
Net Income
Reported
|
|
$
|
23,606
|
|
|
$
|
1.03
|
|
|
$
|
12,571
|
|
|
$
|
0.55
|
|
|
$
|
47,020
|
|
|
$
|
2.05
|
|
|
$
|
41,397
|
|
|
$
|
1.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
Compensation
Income
|
|
$
|
(350)
|
|
|
$
|
(0.02)
|
|
|
$
|
(2,038)
|
|
|
$
|
(0.09)
|
|
|
$
|
(1,043)
|
|
|
$
|
(0.05)
|
|
|
$
|
(2,795)
|
|
|
$
|
(0.12)
|
|
Business Restructuring
Expense
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
4,219
|
|
|
$
|
0.18
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
4,365
|
|
|
$
|
0.19
|
|
Cash-Settled SARs
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(61)
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(145)
|
|
|
$
|
(0.01)
|
|
Environmental
Remediation
Expense
|
|
$
|
405
|
|
|
$
|
0.02
|
|
|
$
|
39
|
|
|
$
|
-
|
|
|
$
|
1,736
|
|
|
$
|
0.08
|
|
|
$
|
384
|
|
|
$
|
0.02
|
|
Adjusted Net
Income
|
|
$
|
23,661
|
|
|
$
|
1.03
|
|
|
$
|
14,730
|
|
|
$
|
0.64
|
|
|
$
|
47,713
|
|
|
$
|
2.08
|
|
|
$
|
43,206
|
|
|
$
|
1.88
|
|
|
* All amounts in this
table are presented after-tax
|
The Company believes that certain non-GAAP measures, in
conjunction with comparable GAAP measures, are useful for
evaluating the Company's operating performance and financial
condition. The Company uses this non-GAAP information as an
indicator of business performance and evaluates management's
effectiveness with specific reference to these indicators.
Management believes that these non-GAAP financial measures provide
useful supplemental information because they exclude
non-operational items that affect comparability between
years. These measures should be considered in addition to,
not as substitutes for or superior to, measures of financial
performance prepared in accordance with GAAP and may differ from
similarly titled measures presented by other companies. The
Company's Annual Report on Form 10-K for the year ended
December 31, 2023 contains additional
information regarding the use of non-GAAP financial measures.
Summary of Third Quarter 2024 Adjusted Net Income
Items
Adjusted net income excludes non-operational deferred
compensation income/expense, cash-settled SARs income/expense,
certain environmental remediation costs and other significant and
infrequent or non-recurring items.
- Deferred Compensation: The third quarter of 2024
reported net income includes $0.4
million of after-tax income versus $2.0 million of after-tax income in the prior
year.
- Environmental Remediation: The third quarter of 2024
reported net income includes $0.4
million of after-tax expense versus less than $0.1 million of after-tax expense in the prior
year.
Table
III
|
|
Reconciliation of
Pre-Tax to After-Tax Adjustments
|
|
Management uses the
non-GAAP adjusted net income metric to evaluate the Company's
operating performance. Management excludes the items listed
in the table below because they are non-operational items.
The cumulative tax effect was calculated using the statutory
tax rates for the jurisdictions in which the transactions
occurred.
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in thousands,
except per share amounts)
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
Pre-Tax
Adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
Compensation
Income
|
|
$
|
(466)
|
|
|
|
|
|
$
|
(2,717)
|
|
|
|
|
|
$
|
(1,390)
|
|
|
|
|
|
$
|
(3,726)
|
|
|
|
|
Business Restructuring
Expense
|
|
$
|
-
|
|
|
|
|
|
$
|
5,628
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
$
|
5,827
|
|
|
|
|
Cash-Settled SARs
Income
|
|
$
|
-
|
|
|
|
|
|
$
|
(82)
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
$
|
(193)
|
|
|
|
|
Environmental
Remediation
Expense
|
|
$
|
541
|
|
|
|
|
|
$
|
52
|
|
|
|
|
|
$
|
2,315
|
|
|
|
|
|
$
|
513
|
|
|
|
|
Total
Pre-Tax Adjustments
|
|
$
|
75
|
|
|
|
|
|
$
|
2,881
|
|
|
|
|
|
$
|
925
|
|
|
|
|
|
$
|
2,421
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative Tax
Effect
on Adjustments
|
|
$
|
(20)
|
|
|
|
|
|
$
|
(722)
|
|
|
|
|
|
$
|
(232)
|
|
|
|
|
|
$
|
(612)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
After-Tax
Adjustments
|
|
$
|
55
|
|
|
$
|
-
|
|
|
$
|
2,159
|
|
|
$
|
0.09
|
|
|
$
|
693
|
|
|
$
|
0.03
|
|
|
$
|
1,809
|
|
|
$
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table
IV
|
|
Deferred
Compensation Plans
|
|
The full effect of the
deferred compensation plans on quarterly pre-tax income was $0.5
million of income versus $2.7 million of income in the prior
year. The quarter-end market prices of Company stock and the
impact of deferred compensation on specific income statement line
items is summarized below:
|
|
|
|
2024
|
|
|
2023
|
|
|
|
9/30
|
|
|
6/30
|
|
|
3/31
|
|
|
12/31
|
|
|
9/30
|
|
|
6/30
|
|
|
3/31
|
|
Stepan
Company
|
|
$
|
77.25
|
|
|
$
|
83.96
|
|
|
$
|
90.04
|
|
|
$
|
94.55
|
|
|
$
|
74.97
|
|
|
$
|
95.56
|
|
|
$
|
103.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in
thousands)
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Deferred
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
(Expense)
|
|
$
|
(556)
|
|
|
$
|
3,101
|
|
|
$
|
(2,729)
|
|
|
$
|
856
|
|
Other, net – Mutual
Fund Gain (Loss)
|
|
|
1,022
|
|
|
|
(384)
|
|
|
|
4,119
|
|
|
|
2,870
|
|
Total
Pre-Tax
|
|
$
|
466
|
|
|
$
|
2,717
|
|
|
$
|
1,390
|
|
|
$
|
3,726
|
|
Total
After-Tax
|
|
$
|
350
|
|
|
$
|
2,038
|
|
|
$
|
1,043
|
|
|
$
|
2,795
|
|
Effects of Foreign
Currency Translation
|
|
The Company's foreign
subsidiaries transact business and report financial results in
their respective local currencies. These results are translated
into U.S. dollars at average foreign exchange rates appropriate for
the reporting period. The table below presents the impact
that foreign currency translation had on select income statement
line items.
|
|
($ in
millions)
|
|
Three Months
Ended
September 30,
|
|
|
Change
|
|
|
Change
Due to
Foreign
Currency
Translation
|
|
|
Nine Months
Ended
September 30,
|
|
|
Change
|
|
|
Change
Due to
Foreign
Currency
Translation
|
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
Net Sales
|
|
$
|
546.8
|
|
|
$
|
562.2
|
|
|
$
|
(15.4)
|
|
|
$
|
(5.6)
|
|
|
$
|
1,654.7
|
|
|
$
|
1,793.6
|
|
|
$
|
(138.9)
|
|
|
$
|
7.0
|
|
Gross Profit
|
|
|
75.7
|
|
|
|
71.2
|
|
|
$
|
4.5
|
|
|
|
(0.9)
|
|
|
|
215.5
|
|
|
|
211.2
|
|
|
$
|
4.3
|
|
|
|
0.1
|
|
Operating
Income
|
|
|
23.9
|
|
|
|
19.5
|
|
|
$
|
4.4
|
|
|
|
(0.4)
|
|
|
|
62.8
|
|
|
|
58.4
|
|
|
$
|
4.4
|
|
|
|
0.2
|
|
Pretax
Income
|
|
|
21.3
|
|
|
|
15.8
|
|
|
$
|
5.5
|
|
|
|
(0.5)
|
|
|
|
58.0
|
|
|
|
52.1
|
|
|
$
|
5.9
|
|
|
|
0.0
|
|
Corporate Expenses
|
|
|
|
Three Months
Ended
September 30,
|
|
|
Nine Months
Ended
September 30,
|
|
($ in
thousands)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Total Corporate
Expenses
|
|
$
|
21,329
|
|
|
$
|
20,071
|
|
|
|
6
|
%
|
|
$
|
59,201
|
|
|
$
|
56,028
|
|
|
|
6
|
%
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
Compensation (Income) Expense
|
|
$
|
556
|
|
|
$
|
(3,101)
|
|
|
NM
|
|
|
$
|
2,729
|
|
|
$
|
(856)
|
|
|
NM
|
|
Business
Restructuring Expense
|
|
$
|
-
|
|
|
$
|
5,628
|
|
|
NM
|
|
|
$
|
-
|
|
|
$
|
5,827
|
|
|
NM
|
|
Environmental Remediation
Expense
|
|
$
|
541
|
|
|
$
|
52
|
|
|
NM
|
|
|
$
|
2,315
|
|
|
$
|
513
|
|
|
NM
|
|
Adjusted Corporate
Expenses
|
|
$
|
20,232
|
|
|
$
|
17,492
|
|
|
|
16
|
%
|
|
$
|
54,157
|
|
|
$
|
50,544
|
|
|
|
7
|
%
|
Adjusted Corporate expenses increased $2.7 million, or 16% for the quarter. This
increase was primarily due to $3.3
million of higher expenses associated with a criminal social
engineering scheme at one of the Company's subsidiaries in
Asia, partially offset by
productivity measures implemented in late 2023.
Table V
|
|
|
|
Stepan
Company Consolidated Balance
Sheets September 30, 2024 and December 31,
2023
|
|
|
|
|
|
September 30,
2024
|
|
|
December 31,
2023
|
|
ASSETS
|
|
|
|
|
|
|
Current
Assets
|
|
$
|
918,158
|
|
|
$
|
851,883
|
|
Property, Plant &
Equipment, Net
|
|
|
1,201,946
|
|
|
|
1,206,665
|
|
Other Assets
|
|
|
293,685
|
|
|
|
304,806
|
|
Total Assets
|
|
$
|
2,413,789
|
|
|
$
|
2,363,354
|
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Current
Liabilities
|
|
$
|
721,293
|
|
|
$
|
607,870
|
|
Deferred Income
Taxes
|
|
|
10,676
|
|
|
|
10,373
|
|
Long-term
Debt
|
|
|
348,670
|
|
|
|
401,248
|
|
Other Non-current
Liabilities
|
|
|
113,785
|
|
|
|
127,373
|
|
Total Stepan Company
Stockholders' Equity
|
|
|
1,219,365
|
|
|
|
1,216,490
|
|
Total Liabilities and
Stockholders' Equity
|
|
$
|
2,413,789
|
|
|
$
|
2,363,354
|
|
Selected Balance
Sheet Information
|
|
The Company's total
debt increased by $31.4 million and cash increased by $22.6 million
versus June 30, 2024. The increase in debt primarily reflects
higher borrowings against the Company's revolving credit facility
that were partially offset by scheduled debt repayments. The
Company's net debt level increased $8.8 million versus June 30,
2024 and the net debt ratio remained constant at 31% in the quarter
(Net Debt and Net Debt Ratio are non-GAAP measures,
reconciliations of which are shown in the table below).
Management uses the non-GAAP net debt metric to show a more
complete picture of the Company's overall liquidity, financial
flexibility and leverage level.
|
|
($ in
millions)
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
December 31,
2023
|
|
Net Debt
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt
|
$
|
688.5
|
|
|
$
|
657.1
|
|
|
$
|
646.0
|
|
|
$
|
654.1
|
|
Cash
|
|
147.3
|
|
|
|
124.7
|
|
|
|
125.8
|
|
|
|
129.8
|
|
Net Debt
|
$
|
541.2
|
|
|
$
|
532.4
|
|
|
$
|
520.2
|
|
|
$
|
524.3
|
|
Equity
|
|
1,219.4
|
|
|
|
1,192.4
|
|
|
|
1,214.5
|
|
|
|
1,216.5
|
|
Net Debt +
Equity
|
$
|
1,760.6
|
|
|
$
|
1,724.8
|
|
|
$
|
1,734.7
|
|
|
$
|
1,740.8
|
|
Net Debt / (Net Debt +
Equity)
|
|
31
|
%
|
|
|
31
|
%
|
|
|
30
|
%
|
|
|
30
|
%
|
The major working
capital components were:
|
|
($ in
millions)
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
December 31,
2023
|
|
Net
Receivables
|
$
|
434.1
|
|
|
$
|
437.3
|
|
|
$
|
446.6
|
|
|
$
|
422.1
|
|
Inventories
|
|
296.7
|
|
|
|
266.0
|
|
|
|
257.1
|
|
|
|
265.6
|
|
Accounts
Payable
|
|
(257.1)
|
|
|
|
(251.2)
|
|
|
|
(256.9)
|
|
|
|
(233.0)
|
|
|
$
|
473.7
|
|
|
$
|
452.1
|
|
|
$
|
446.8
|
|
|
$
|
454.7
|
|
Table
VI
|
|
Reconciliations of
Non-GAAP EBITDA and Adjusted EBITDA
|
|
Management uses the
non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the
Company's operating performance. Management excludes the
items listed in the table below because they are non-operational
items. Refer to the Income Statement on Table I for a bridge
between Operating Income and Net Income.
|
|
|
|
Three Months
Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
26.3
|
|
|
$
|
15.2
|
|
|
$
|
3.7
|
|
|
$
|
(21.3)
|
|
|
$
|
23.9
|
|
Depreciation and Amortization
|
|
$
|
17.9
|
|
|
$
|
8.2
|
|
|
$
|
1.5
|
|
|
$
|
0.5
|
|
|
$
|
28.1
|
|
Other, Net
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1.0
|
|
|
$
|
1.0
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
53.0
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.4)
|
|
|
$
|
(0.4)
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.5
|
|
|
$
|
0.5
|
|
Adjusted
EBITDA
|
|
$
|
44.2
|
|
|
$
|
23.4
|
|
|
$
|
5.2
|
|
|
$
|
(19.7)
|
|
|
$
|
53.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
September 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
15.4
|
|
|
$
|
21.8
|
|
|
$
|
2.4
|
|
|
$
|
(20.1)
|
|
|
$
|
19.5
|
|
Depreciation and Amortization
|
|
$
|
16.3
|
|
|
$
|
7.9
|
|
|
$
|
1.5
|
|
|
$
|
0.6
|
|
|
$
|
26.3
|
|
Other, Net
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.7)
|
|
|
$
|
(0.7)
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
45.1
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(2.7)
|
|
|
$
|
(2.7)
|
|
Cash
Settled SARs
|
|
$
|
(0.1)
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.1)
|
|
Business
Restructuring
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
5.6
|
|
|
$
|
5.6
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
Adjusted
EBITDA
|
|
$
|
31.6
|
|
|
$
|
29.7
|
|
|
$
|
3.9
|
|
|
$
|
(17.2)
|
|
|
$
|
48.0
|
|
|
|
|
|
|
|
Nine Months
Ended
September 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
69.4
|
|
|
$
|
37.2
|
|
|
$
|
15.3
|
|
|
$
|
(59.2)
|
|
|
$
|
62.7
|
|
Depreciation and Amortization
|
|
$
|
53.5
|
|
|
$
|
24.4
|
|
|
$
|
4.5
|
|
|
$
|
1.3
|
|
|
$
|
83.7
|
|
Other, Net
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
4.6
|
|
|
$
|
4.6
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
151.0
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(1.4)
|
|
|
$
|
(1.4)
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
2.3
|
|
|
$
|
2.3
|
|
Adjusted
EBITDA
|
|
$
|
122.9
|
|
|
$
|
61.6
|
|
|
$
|
19.8
|
|
|
$
|
(52.4)
|
|
|
$
|
151.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
Ended
September 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
57.6
|
|
|
$
|
48.1
|
|
|
$
|
8.7
|
|
|
$
|
(56.0)
|
|
|
$
|
58.4
|
|
Depreciation and Amortization
|
|
$
|
47.7
|
|
|
$
|
24.5
|
|
|
$
|
4.3
|
|
|
$
|
1.9
|
|
|
$
|
78.4
|
|
Other, Net
Income (Expense)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3.3
|
|
|
$
|
3.3
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
140.1
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(3.7)
|
|
|
$
|
(3.7)
|
|
Cash
Settled SARs
|
|
$
|
(0.2)
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.2)
|
|
Business
Restructuring
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
5.8
|
|
|
$
|
5.8
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.5
|
|
|
$
|
0.5
|
|
Adjusted
EBITDA
|
|
$
|
105.1
|
|
|
$
|
72.6
|
|
|
$
|
13.0
|
|
|
$
|
(48.2)
|
|
|
$
|
142.5
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/stepan-reports-third-quarter-2024-results-302291240.html
SOURCE Stepan Company